• Delorean receives FY2025 R&D cash refund of $5.76 million
• Further cash refund expected next financial year for FY2026 expenditure
• R&D Tax Incentive program provides cash refund for eligible R&D activities

Delorean Corporation Ltd (ASX: DEL) has announced that it has received a FY2025 Research and Development (R&D) cash refund of $5.76 million. The refund is related to eligible R&D expenditure incurred during FY2025. The company also expects to receive a further cash refund next financial year in connection with expenditure incurred in the current financial year (FY2026). The Australian Federal Government's R&D Tax Incentive program provides a cash refund on eligible research and development activities performed by eligible Australian companies. Delorean is a leading Australian bioenergy company that specializes in the design, build, ownership and management of bioenergy infrastructure. The company is vertically integrated, with an Engineering Division, Infrastructure Division, and Energy Retail Division, allowing it to deliver bioenergy projects across the full lifecycle, from project conception to completion, processing organic waste, generating renewable energy, and monetizing the sale of green electricity, heat, and gas.